Research Commercialization Academy (BETA 0.01)

Back Office Services for NCET2.org

 

Author: Andrew Ward


Source: The Financial Times


Interest: City professionals will be urged to pour some of their personal wealth into medical research and technology this week as part of a push to attract more angel investment into UK life sciences. Bankers, lawyers and business executives are among the targets of a campaign to match wealthy individuals with early-stage biotech and medical technology companies in need of funding.


Link: http://www.ft.com/cms/s/0/8584ac2a-5705-11e4-a45c-00144feab7de.html#axzz3GsaVYgN4

Leave a Comment

Author: Fiona Barry


Source: BioPharma Reporter.com


Interest: GSK and venture capitalists Avalon have launched two early-stage R&D biotechs in San Diego, California. Silarus Therapeutics and Thyritope Biosciences will each receive $10m (€8m) in a Series A financing round to investigate the hormone behind anaemia, and anautoimmune disease.


Link: http://tinyurl.com/ol5lm7m

Leave a Comment

Author: Businesswire


Source: Businesswire


Interest: Dutch venture capitalist Aglaia has announced the launch of Aglaia Oncology Fund II. Investors contribute a total of $65 million to the fund, whose target size is $80 to $100 million. Like its predecessor Aglaia Oncology Fund I, the fund is backed by high-net-worth families. The group of investors has now been expanded to include several institutional investors, including the European Investment Fund (EIF), which has made a substantial commitment.


Link: http://www.businesswire.com/news/home/20140918005320/en/Biotech-Venture-Capital-Firm-Aglaia-Launches-65#.VCAVbJSSy0c

Leave a Comment

Author: PRNewswire


Source: The Providence Journal


Interest: The National Institute of Health has awarded a Phase I Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for a point-of-care hepatitis C diagnostic system. Daktari, which commercializes diagnostic platforms to meet the health care needs in Africa, Asia, and resource-limited settings worldwide, will use the grant funding to continue development of the Daktari HCV assay, which runs on the same point-of-care platform as the Daktari CD4 test used to monitor HIV patients.


Link: http://www.providencejournal.com/business/press-releases/20140603-daktari-awarded-nih-phase-i-sbir-for-its-hcv-diagnostic.ece

Leave a Comment

Author: Here And Now


Source: Here And Now


Interest: The National Institutes of Health will soon begin requiring scientists to test new drugs on both male and female animals. Researchers now tend to use mostly male animals in pre-clinical tests, even for drugs that will also be used by women.


Link: http://hereandnow.wbur.org/2014/05/20/nih-female-animals

Leave a Comment

Author: Curtis Chan


Source: Penn State News


Interest: UNIVERSITY PARK, Pa. -- Mohammad Reza Abidian, professor of biomedical engineering, has received a $1.8 million single-PI grant from the National Institutes of Health's Institute for Neurological Disorders (NINDS). The five-year grant is titled, "Neural Tissue Engineering Based on Combinatorial Effects of Multiple Guidance Cues."


Link: http://news.psu.edu/story/316408/2014/05/20/research/18m-nih-grant-will-support-study-nervous-systems-underlying

Leave a Comment

Author: PR Newswire


Source: University of Maryland Ventures


Interest: MedImmune, the global biologics research and development arm of AstraZeneca, and the University System of Maryland announced today that the initial research collaboration between MedImmune and the University of Maryland, Baltimore (UMB) has been expanded to include the University of Maryland, College Park and the University of Maryland, Baltimore County. The collaborators have also announced that they have identified the first five research projects to be undertaken under the expanded agreement.


Link: http://www.prnewswire.com/news-releases/medimmune-expands-university-system-of-maryland-research-collaboration-257143241.html

Leave a Comment

Author: PR Newswire


Source: Association of University Research Parks


Interest: In the face of rising drug research and development costs and continued pressures against increasing prices for medicines and health care services, the biopharmaceutical industry must find ways to increase innovation and efficiencies. The Association of University Research Parks (AURP) today announced that leaders from industry and academia will come together at the Janssen Research & Development West Coast Research Center in San Diego on June 23, 2014, for AURP's BioParks 2014 Meeting .


Link: http://www.marketwatch.com/story/university-bioparks-serve-as-source-of-innovation-as-pharmaceutical-rd-model-shifts-2014-04-29

Leave a Comment

Author: Manuel Baigorri, Albertina Torsoli and David Welch


Source: Bloomberg


Interest: Sanofi (SAN), maker of the world’s top-selling diabetes treatment, has joined the bidding for Merck & Co. (MRK)’s over-the-counter health-products unit, people with knowledge of the matter said.


Link: http://www.bloomberg.com/news/2014-03-24/sanofi-said-to-join-bidders-for-merck-s-consumer-health-business.html

Leave a Comment

Author: E.B. Solomont


Source: St. Louis Business Journal


Interest: For a $14 billion company, Monsanto Co.’s four-person venture group is small but mighty. As I wrote in this week’s edition of the Business Journal, Monsanto Growth Ventures was formed in 2011 and to date has had a hand in seven deals, including Monsanto’s $1 billion acquisition of Climate Corp. last year, and the more recent launch of Preceres LLC, a company focused on biological pest and weed control, with a group of MIT scientists.


Link: http://www.bizjournals.com/stlouis/blog/2014/03/monsanto-s-4-power-investors.html

Leave a Comment

Author: Timothy Hay


Source: http://blogs.wsj.com/


Interest: The firm, founded in 2009 by Netscape Communications Corp. co-founder Marc Andreessen and Opsware Inc. and LoudCloud Inc. founder Ben Horowitz, is among a small number of firms that can raise and fairly quickly deploy funds of more than $1 billion.


Link: http://blogs.wsj.com/venturecapital/2014/03/27/andreessen-horowitz-raises-yet-another-1-5-billion-fund/

Leave a Comment

Author: Sandra E. Garcia


Source: The New York Times


Interest: Inside the Sweets Building, a renovated structure that was formerly a confectionery research lab, is Harlem Biospace, a new business incubator focused on biotechnology. Situated on West 127th Street between Amsterdam and Convent Avenues, north of Columbia University and south of City College, Harlem Biospace is an effort to tap the scientific talent and entrepreneurial spirit of the two storied educational institutions.


Link: http://www.nytimes.com/2014/03/24/nyregion/rejuvenated-harlem-building-becomes-a-business-incubator-for-biotechnology.html?hpw&rref=nyregion&_r=0

Leave a Comment

Author: Nicole Bolton


Source: BusinessWire


Interest: LOS ANGELES--(BUSINESS WIRE)--Bruin Biometrics, LLC (“BBI”), a medical device company with two biometric sensing products ready for market in Europe and the United States, announced it has closed a $10 million round of funding which was oversubscribed by almost $2.7 million. The funds will be deployed to market the developed products, complete clinical trials and continue R&D on the product pipeline...


Link: http://goo.gl/HGbKpy

Leave a Comment

Author: Sustainable Business News


Source: GreenBiz


Interest: Investors who have shied away from clean-tech companies for the past two years haven't lost interest, but are broadening their scope into more areas of sustainability, according to a report by Cleantech IQ [PDF].


Link: http://www.greenbiz.com/blog/2014/02/05/sustainability-new-buzzword-venture-capital

Leave a Comment

Author: Cynthia Graber


Source: Scientific American


Interest: About three-quarters-of-a-million open heart surgeries take place annually in the U.S., according to the American Heart Association. Applying sutures or staples during these procedures costs precious seconds and can cause damage. Researchers have sought adhesives that could quickly seal tissue. But currently available substances don’t work in the presence of liquid, or can’t withstand all that forceful pumping, or are toxic.


Link: http://www.scientificamerican.com/podcast/episode/new-glue-could-seal-heart-surgeries-14-01-13/

Leave a Comment

Author: http://www.govconwire.com/


Source: http://www.govconwire.com/


Interest: Mercom Capital Group has released a healthcare information technology report showing that venture capital funding for that sector reached a total of $2.2 billion in 2013, HIT Consultant Media reported Tuesday.


Link: http://www.govconwire.com/2014/01/healthcare-it-venture-capital-funding-reached-2-2b-in-2013/

Leave a Comment

Author: Chris Seper


Source: MedCity News


Interest: Now in its 11th year, MidAmerica Healthcare Venture Forum unites active healthcare venture capitalists and corporate business development executives with more than 30 of the most promising Midwest-based healthcare startups to facilitate investment opportunities and showcase dealflow originating in the Midwest.


Link: http://medcitynews.com/2014/01/midamerica-healthcare-venture-forum-brings-together-venture-capitalists-startups/

Leave a Comment

Author: Chad Swiatecki


Source: Austin Business Journal


Interest: University of Texas scientists and commercialization specialists are hoping that an advance developed at the school which improves the effectiveness of vaccines could mean big business from pharmaceutical giants like GlaxoSmithKline.


Link: http://www.bizjournals.com/austin/news/2014/01/06/ut-vaccine-research-eyed-for.html

Leave a Comment

Author: Christina Farr


Source: http://venturebeat.com/


Interest: The Ellison Medical Foundation has been one of the largest funding sources for promising research into anti-aging technologies. According to the San Francisco Business Times, the New York-based foundation is facing a funding crunch, and so it may shift its focus to other areas.


Link: http://venturebeat.com/2013/12/19/larry-ellisons-foundation-cuts-funding-for-anti-aging-research/

Leave a Comment

Author: Scott Dance


Source: The Baltimore Sun


Interest: Northrop Grumman Corp. has signed on as a sponsor of DreamIt Health Baltimore, a business accelerator backed by Johns Hopkins University and BioHealth Innovation Inc.The accelerator gives startups $50,000 in seed funding, help gathering customers, and accounting and legal support, along with access to the expertise of the sponsors. Philadelphia-based accelerator DreamIt Ventures launched the incubator.


Link: http://www.baltimoresun.com/news/opinion/bs-bz-northrop-health-accelerator-20131216,0,1799436.story

Leave a Comment